Sean Lee
Stock Analyst at HC Wainwright & Co.
(4.16)
# 497
Out of 5,122 analysts
98
Total ratings
35.42%
Success rate
24.58%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KZIA Kazia Therapeutics | Maintains: Buy | $13 → $18 | $6.43 | +179.94% | 6 | Dec 12, 2025 | |
| CTSO Cytosorbents | Maintains: Neutral | $1 → $0.75 | $0.62 | +20.58% | 14 | Nov 14, 2025 | |
| SENS Senseonics Holdings | Maintains: Buy | $1.4 → $19 | $5.58 | +231.54% | 3 | Nov 6, 2025 | |
| PSTV Plus Therapeutics | Maintains: Buy | $3 → $2 | $0.54 | +272.16% | 13 | Nov 3, 2025 | |
| ATEC Alphatec Holdings | Maintains: Buy | $20 → $24 | $21.12 | +13.64% | 13 | Oct 31, 2025 | |
| NVAX Novavax | Maintains: Buy | $10 → $11 | $6.67 | +64.92% | 2 | Oct 23, 2025 | |
| DWTX Dogwood Therapeutics | Maintains: Buy | $10 → $12 | $4.12 | +191.26% | 2 | Sep 30, 2025 | |
| AKTX Akari Therapeutics, | Reiterates: Buy | $1.6 | $0.28 | +479.50% | 2 | Sep 9, 2025 | |
| CASI CASI Pharmaceuticals | Reiterates: Buy | $4 | $0.82 | +388.28% | 10 | Sep 3, 2025 | |
| MYO Myomo | Maintains: Buy | $9.5 → $5 | $0.95 | +424.99% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $7.52 | +86.17% | 14 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $64.25 | -37.74% | 10 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.44 | +47.85% | 3 | Mar 26, 2025 |
Kazia Therapeutics
Dec 12, 2025
Maintains: Buy
Price Target: $13 → $18
Current: $6.43
Upside: +179.94%
Cytosorbents
Nov 14, 2025
Maintains: Neutral
Price Target: $1 → $0.75
Current: $0.62
Upside: +20.58%
Senseonics Holdings
Nov 6, 2025
Maintains: Buy
Price Target: $1.4 → $19
Current: $5.58
Upside: +231.54%
Plus Therapeutics
Nov 3, 2025
Maintains: Buy
Price Target: $3 → $2
Current: $0.54
Upside: +272.16%
Alphatec Holdings
Oct 31, 2025
Maintains: Buy
Price Target: $20 → $24
Current: $21.12
Upside: +13.64%
Novavax
Oct 23, 2025
Maintains: Buy
Price Target: $10 → $11
Current: $6.67
Upside: +64.92%
Dogwood Therapeutics
Sep 30, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $4.12
Upside: +191.26%
Akari Therapeutics,
Sep 9, 2025
Reiterates: Buy
Price Target: $1.6
Current: $0.28
Upside: +479.50%
CASI Pharmaceuticals
Sep 3, 2025
Reiterates: Buy
Price Target: $4
Current: $0.82
Upside: +388.28%
Myomo
Aug 12, 2025
Maintains: Buy
Price Target: $9.5 → $5
Current: $0.95
Upside: +424.99%
May 9, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $7.52
Upside: +86.17%
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $64.25
Upside: -37.74%
Mar 26, 2025
Reiterates: Buy
Price Target: $11
Current: $7.44
Upside: +47.85%